Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study
, , , , , und
02. Feb. 2022
Über diesen Artikel
Online veröffentlicht: 02. Feb. 2022
Seitenbereich: 325 - 332
Eingereicht: 05. Okt. 2020
Akzeptiert: 06. März 2021
DOI: https://doi.org/10.2478/sjecr-2021-0057
Schlüsselwörter
© 2021 Ravinder Singh et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Singh, Ravinder
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Rao, Harbir Kaur
Gian Sagar Medical College and HospitalPatiala
Sharma, Anil
Amil PharmaceuticalsNew Delhi
Singh, Thakur Gurjeet
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Parashar, Abhimanyu
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Singh, Randhir
MM College of Pharmacy, Maharishi Markandeshwar University MullanaAmbala, India
Saini, Balraj
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India